The use of supplemental hydrocortisone in the management of persistent pulmonary hypertension of the newborn.
Samia AleemCliff RobbinsBrianna MurphyStephen ElliottChristiana AkinyemiNicholas ParedesVeeral N ToliaKanecia O ZimmermanRonald N GoldbergDaniel K BenjaminRachel Gottron GreenbergPublished in: Journal of perinatology : official journal of the California Perinatal Association (2021)
There was no association between hydrocortisone receipt and death, CLD, or oxygen at discharge in our cohort. Prospective studies are needed to evaluate the effectiveness of hydrocortisone in infants with PPHN.